1. Stealthy lentiviral vectors: Breaking the barriers to systemic in vivo gene delivery
Keating Al, Carlisle Rc, Mitrophanous Ka, Seymour Lw, Fisher Kd
Lentiviral vector (LVV)-mediated chimeric antigen receptor (CAR)-T cell therapy has transformed the landscape for blood cancer treatment through genetic modification of patients' T cells. Yet, the complexity of the manufacturing process makes this therapy inaccessible for many patients. Systemic intravenous delivery…
Read the article